Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Monday, August 31, 2026

Snapshot: Aug 31, 2026 · 6:00 PM 100 stocks analyzed

Up Day

Mon, Aug 31, 2026 Divergent Normal

Nasdaq surges 1.5% on tech leadership while utilities crater on wildfire liability shock, creating a divergent tape of narrow strength masking deep sector fissures.

55% Tech and mega-cap momentum powered a 1.49% Nasdaq 100 rally with BKHAR, SSM, and a wave of biotech/SPAC plays posting 20%+ gains, offsetting broad small-cap weakness as Russell 2000 fell 1.29% and mid-caps dropped 1.08%. The market regime split cleanly—large-cap tech led while smaller names retreated, exemplified by SSM's 63% jump on a sports franchise LOI and NeoVolta's 27% surge on a battery supply deal, grounding the index gains in concrete news rather than speculation.
30% California's removal of wildfire liability caps triggered a 20%+ collapse in utilities, with PG&E crashing 20% and Edison International down 23% after lawmakers stripped protections from amended legislation, creating a sudden re-pricing of regulatory risk that dominated the losers list and dragged Healthcare to a 34% share of declines despite sector gainers like SSM and InnSuites posting strong reversals.
15% Single-stock volatility remained elevated but routine, with EYES imploding 95% (likely a clinical or bankruptcy event), BKHAR skyrocketing 84% (probable shareholder vote or merger close), and five first-time debutants entering the gainers list, signaling that despite divergent macro moves, the undercurrents favored story-driven micro-caps over index-wide conviction.

Healthcare drove 34% of losers 5 names returned after long absences MIMI · 3-day losers streak AACPR — first appearance KLXER — first appearance

Market Regime

Mon, Aug 31, 2026 Risk-On conf: medium macro · prototype

+26

Tailwind −100 … +100 · + tailwind / − headwind

VIX14.9 p9 Drawdown-1.5% Held5d · building SinceAug 25

Top drivers: VIX percentile ▲ S&P drawdown (60d) ▲ Small-cap leadership ▼

processId: history-market-regime

Market Indexes

Mon, Aug 31, 2026 13

S&P 500

7,686.14

+33.28

+0.43%

Dow Jones

53,185.90

−231.26

-0.43%

NASDAQ Composite

26,370.89

+390.70

+1.50%

NASDAQ 100

29,456.97

+433.79

+1.49%

DJ US Total Market

76,015.30

+224.16

+0.30%

Russell 1000

4,187.23

+13.60

+0.33%

S&P MidCap 400

3,760.24

−41.06

-1.08%

Russell 2000

2,956.45

−38.63

-1.29%

Russell 2500

1,264.19

−6.66

-0.52%

Russell 3000

4,368.60

+11.26

+0.26%

Nasdaq Financial-100

7,729.78

−25.41

-0.33%

NIFTY 50

24,080.40

−254.15

-1.04%

VIX

14.92

−0.53

-3.43%

Biggest Gainers

Mon, Aug 31, 2026 50

BKHAR

Black Hawk Acquisition Corporation Rights

$1.28+$0.59

+84.2%

NASDAQ · Mkt cap $1.7 M

No news headlines were found in the last 48 hours, but the 84% gain in BKHAR rights on this date likely reflects a shareholder vote result, merger completion announcement, or other corporate action tied to the underlying Black Hawk Acquisition blank-check company.

BKHAR is a rights security tied to a SPAC, and rights typically spike sharply when the parent company completes a merger, announces a definitive deal, or distributes cash proceeds to shareholders. Since no financial news appeared in the Yahoo Finance RSS feed for the past 48 hours, the catalyst either occurred but was not yet indexed by this news source, was announced through a press release or SEC filing rather than a wire service story, or involved a scheduled corporate action (such as a merger closing or redemption that was previously announced). SPAC rights are structurally volatile and illiquid, making them susceptible to outsized moves on relatively small trading volume. The ranking as the 1 gainer of the day on a 84% move is consistent with a discrete catalyst rather than gradual drift.

SSM

Sono Group N.V.Consumer Cyclical

$2.67+$1.72

+63.2%

NASDAQ · Mkt cap $3.8 M

Sono Group announced a letter of intent to combine with Sports One and enter professional sports franchise ownership across major U.S. leagues, paired with a sports intelligence business, driving a 63% single-day surge.

The headline establishes a concrete M&A event: Sono Group has signed a non-binding letter of intent to merge with Sports One, gaining minority ownership stakes in NFL, NBA, MLB, and NHL franchises while combining that with a sports analytics and athlete-valuation platform. This represents a significant strategic pivot from the company's prior automotive solar business toward sports investment and technology. The magnitude of the move—63% in a single session—suggests the market views this as a transformative development with material upside potential. However, the announcement is formally just a letter of intent, which is non-binding. The actual valuation impact and feasibility of securing franchise stakes and executing the integration remain uncertain, and the headline provides no detail on deal terms, financing, or likelihood of completion.

APACR

StoneBridge Acquisition II Corporation Rights

$0.13+$0.04

+44.1%

LABT

Lakewood-Amedex Biotherapeutics Inc.Healthcare

$2.51+$0.96

+42.3%

NASDAQ · Mkt cap $3.8 M

No news headlines were found in the last 48 hours to explain the 42% surge in LABT stock, making the specific catalyst unclear and suggesting the move may be driven by technical factors, rumors, or delayed announcements not yet captured in major news feeds.

Lakewood-Amedex Biotherapeutics experienced a substantial intraday gain of 42.29% to reach $2.51 per share on August 31, 2026, yet no recent news articles are available in the Yahoo Finance RSS feed for the prior 48 hours. This disconnect between significant price movement and absence of timely headline coverage is notable. For a small-cap biotherapeutics company trading at this price level, catalysts that commonly drive large single-day jumps include clinical trial results, FDA decisions, partnership announcements, or short-squeeze activity. Without confirmed headlines, potential explanations remain speculative and could include delayed market absorption of older news, social media-driven retail interest, technical reversal off recent lows, or unconfirmed rumors. The absence of news does not rule out a real catalyst; it may simply indicate a lag in news indexing or that the triggering event occurred outside traditional press release channels.

AACPR

Apogee Acquisition Corp Rights

$0.19+$0.05

+34.2%

Ticketplus Ltd.

$10.25+$2.58

+33.0%

FIXX

Homology Medicines Inc

$14.87+$3.60

+31.9%

ADOC

Edoc Acquisition Corp.Financial Services

$0.59+$0.13

+28.9%

SST

SPDR Blmbg Barclays ST Treasury ETFIndustrials

$2.21+$0.50

+27.1%

NYSE · Mkt cap $22 M

No relevant news about SST was provided; the 27% surge in this short-duration Treasury ETF likely reflects a sharp drop in short-term interest rates or a significant market flight-to-safety event on August 31, 2026.

The only headline supplied concerns MapQuest's app store ranking and is entirely unrelated to SST, a Bloomberg Barclays short-term Treasury ETF. SST tracks ultra-safe, liquid short-duration government bonds. A 27% single-day gain in such an instrument is unusual and points to a major shift in the fixed-income market rather than company-specific news. The most probable structural cause is a steep decline in short-term Treasury yields, which would drive up bond prices inversely. This could stem from a major risk-off event, Federal Reserve policy surprise, economic data shock, or geopolitical crisis that sparked demand for safe havens. Without access to Treasury market data or economic releases from that date, the specific trigger cannot be identified from the evidence provided.

KLXER

KLX Energy Services Holdings, Inc. Rights

$0.14+$0.03

+27.1%

NEOV

NeoVolta, Inc.Industrials

$4.24+$0.90

+26.9%

NASDAQ · Mkt cap $214 M

NeoVolta announced a strategic five-year battery supply and manufacturing partnership with SK On securing 9 GWh of LFP cell supply and a reciprocal pack purchase arrangement, likely driving the 26.94% gain as a major commercial validation of its energy storage business model.

The headline describes a substantial strategic collaboration between NeoVolta and SK On, a major battery manufacturer. The deal includes two key components: NeoVolta securing a five-year supply of 9 GWh of U.S.-manufactured LFP battery cells, and SK On committing to purchase energy storage packs from NeoVolta Power. For a smaller battery and energy storage company, this type of multi-year supply agreement with a credible tier-one partner typically signals material revenue visibility, de-risking of supply chain, and validation of product-market fit. The stock's jump to rank 11 among daily gainers reflects investor enthusiasm about the commercial viability and scale potential this partnership represents. The specificity of the 9 GWh volume and five-year term suggests a binding commitment rather than a preliminary agreement.

PETZ

TDH Holdings IncReal Estate

$1.20+$0.31

+26.1%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours, so the 26% gain on PETZ likely reflects either a delayed market reaction to an earlier announcement, technical/short-squeeze dynamics, or an undisclosed development.

The absence of any recent news headlines makes it impossible to identify a specific catalyst for this 26% intraday jump. PETZ (TDH Holdings Inc) is a low-priced NASDAQ stock, and stocks in this category are often targets for short-squeeze activity, retail momentum trading, or technical breakouts that can produce outsized single-day moves without accompanying news. It is also possible that a material announcement occurred outside the Yahoo Finance RSS feed capture window, or that the market is reacting to developments from earlier in the week that are only now gaining traction. Without either news or detailed knowledge of PETZ's structure, shareholder composition, or recent price action patterns, the specific driver cannot be determined with confidence.

LTCH

Latch, Inc.Technology

$0.19+$0.04

+25.4%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 25.41% gain in LTCH appears driven by technical factors, market sentiment shifts, or unreported developments rather than a specific announced event.

The absence of any news in the provided Yahoo Finance RSS feed over the last 48 hours makes it difficult to pinpoint a definitive catalyst for Latch's sharp single-day rally. LTCH is a building access and smart home software company that has historically been volatile and sensitive to shifts in market sentiment, investor positioning, and real estate sector dynamics. Given the stock's low absolute price of $0.19, it may be more susceptible to technical momentum, short covering, or retail sentiment swings than larger-cap names. The move could reflect delayed market reaction to an earlier announcement, changes in investor positioning around the company's business prospects, or simply algorithmic or retail-driven momentum in a low-liquidity name. Without access to headlines or structural context about current short interest or insider activity, the precise driver remains opaque.

BREZR

Breeze Holdings Acquisition Corp.

$0.26+$0.05

+22.8%

OYSER

Oyster Enterprises II Acquisition Corp Rights

$0.14+$0.02

+21.6%

USDEW

StablecoinX Inc. Warrants

$1.80+$0.32

+21.6%

DPRO

Draganfly Inc.

$5.43+$0.96

+21.6%

MOBX

Mobix Labs, Inc.Technology

$1.32+$0.23

+21.1%

NASDAQ · Mkt cap $18 M

Mobix Labs surged 21.1% on news that its pending drone acquisition Vision Aerial opened orders for the Vulcan drone and projects 93% revenue growth in 2027, signaling strong commercial momentum ahead of the deal close.

Mobix Labs announced concrete commercial progress at Vision Aerial, its acquisition target, with three coordinated press releases on August 31st highlighting that Vision Aerial has begun production of its Vulcan drone family, opened customer orders, and projects approximately 93% revenue growth in 2027. This combination of operational milestones—moving from acquisition announcement to active order-taking and aggressive revenue guidance—likely reassured investors about the deal's viability and the acquired business's near-term growth trajectory. The stock's 21% gain ranks it 18th among daily gainers, consistent with a micro-cap or small-cap benefiting materially from acquisition-driven upside visibility. The timing and specificity of the announcements suggest a coordinated investor communications effort to validate the strategic rationale.

NCPL

Netcapital Inc.Financial Services

$0.70+$0.12

+20.3%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours, so the 20% rally on NCPL cannot be directly attributed to a public announcement. The move likely reflects either retail speculation, options activity, or a delayed market reaction to an earlier event.

The absence of recent headlines makes it impossible to pinpoint a specific catalyst for Netcapital's sharp 20% gain. However, micro-cap stocks like NCPL, which trade at $0.70 and likely have lower liquidity, are prone to outsized intraday swings driven by factors other than fundamental news. Possible explanations include technical buying (breakout from support), options-driven gamma activity, short covering if the stock had elevated short interest, retail social media momentum, or a delayed market reaction to an event that occurred before the 48-hour window. Without access to volume data, options flow, or short interest trends, none of these can be confirmed as the actual cause.

USDE

StablecoinX Inc.Financial Services

$8.85+$1.30

+19.4%

NASDAQ · Mkt cap $74 M

No news headlines were found in the last 48 hours, so the 19.37% gain likely reflects either a delayed market reaction to an earlier announcement, technical or momentum trading, or an undisclosed catalyst not yet captured in financial news feeds.

The absence of recent headlines makes it difficult to pinpoint a specific catalyst for USDE's strong 19.37% gain today. Stablecoin-related equities can be sensitive to regulatory developments, cryptocurrency market sentiment, adoption announcements, or shifts in digital asset demand, but none of these are evident in the provided information. The stock's rank as the 20th biggest gainer suggests real volume and interest rather than thin-traded noise. Possible explanations include a delayed reaction to news released more than 48 hours ago that has now gained traction, short covering or technical momentum buying if the stock trades with low float, or an announcement that has not yet propagated to the Yahoo Finance RSS feed. Without accompanying headlines or structural details about the company's business, we cannot distinguish among these scenarios.

FBLG

FibroBiologics, Inc. Common StockHealthcare

$1.71+$0.27

+19.1%

NASDAQ · Mkt cap $7.6 M

No headlines were published in the last 48 hours for FBLG, so the 19% gain likely reflects either a delayed market reaction to earlier news, technical/short-covering activity, or an untracked announcement, but the specific cause cannot be determined from available information.

FibroBiologics is a small-cap regenerative medicine company, and the absence of any recent news headlines despite a significant single-day gain of 19% suggests the catalyst is either not yet indexed by major financial RSS feeds, represents a delayed market reaction to older news, or stems from technical factors such as short covering or options-related positioning. Small-cap biotech stocks are particularly susceptible to gaps between actual news timing and RSS publication, and they can also experience sharp moves on clinical trial announcements, regulatory decisions, partnership news, or shifts in investor sentiment that may not immediately populate mainstream financial feeds. Without access to company press releases, investor relations announcements, or specialized biotech news sources, the specific driver remains unknown.

EMAT

Evolution Metals & Technologies Corp.Basic Materials

$3.88+$0.61

+18.7%

NASDAQ · Mkt cap $2.0 B

No news headlines were found in the past 48 hours for EMAT, so the 18.65% gain cannot be directly attributed to a public announcement; the move likely reflects technical, sector-wide momentum, or unverified market chatter.

The absence of news in the headline feed is the clearest finding here. EMAT is a micro-cap metals and technology company, and such stocks are often sensitive to sector rotation, commodity price movements, or technical breakouts that do not require news catalysts. A +18.65% single-day move in a stock trading under $4 could reflect short-covering, retail momentum, a delayed earnings or operational announcement that did not reach the RSS feed, or simply algorithmic rebalancing in a thinly traded name. Without specific headline evidence, we cannot confirm whether this was driven by fundamentals or sentiment.

WCT

Wellchange Holdings Company LimitedTechnology

$1.27+$0.19

+18.1%

NASDAQ · Mkt cap $4.1 M

Wellchange Holdings announced the closing of a $7.5 million public offering of Class A ordinary shares on August 31, 2026, which likely triggered the 18.15% gain as investors reacted positively to the capital raise and potential business expansion.

The headline confirms that Wellchange, a Hong Kong-based enterprise software solutions provider trading on NASDAQ, successfully closed a $7.5 million public offering of Class A ordinary shares on the same day as the price jump. Capital raises of this magnitude can drive gains if investors interpret the funding as enabling growth, reducing financial stress, or signaling management confidence in future prospects. The timing of the announcement and stock price move on the same day establishes temporal proximity. However, the headline text is truncated and does not provide detail on how the company plans to deploy capital, whether there were any strategic rationales disclosed, or what the market's specific sentiment drivers were. The 18.15% gain is material but not extraordinary for a small-cap stock on a financing announcement, suggesting moderate market enthusiasm rather than a blockbuster catalyst.

SORA

Top Win International LimitedConsumer Cyclical

$1.91+$0.28

+17.2%

NASDAQ · Mkt cap $57 M

No news headlines were found in the last 48 hours, so the 17.18% gain likely reflects a technical rebound, delayed reaction to earlier news, retail interest, or a company-specific catalyst not yet covered by major financial media.

Top Win International Limited (SORA) climbed 17.18% on August 31, 2026, to rank among the day's top 24 gainers, but no news headlines appeared in the most recent 48-hour window. This gap between price action and available news coverage is common in lower-volume NASDAQ-listed stocks. The move could reflect several factors: a technical bounce after prior weakness, accumulation by retail traders or short covering, a press release or announcement not yet picked up by mainstream financial feeds, or reaction to broader market sentiment or sector trends. Without corroborating headlines or structural information about SORA's business, capital structure, or known short interest, attribution remains speculative. The lack of any news coverage also raises the possibility of a delayed market reaction to information released earlier, or coverage that simply hasn't reached the RSS feeds sampled.

Definitive Healthcare Corp.Healthcare

$0.95+$0.14

+17.2%

NASDAQ · Mkt cap $77 M

No news headlines were available in the past 48 hours for Definitive Healthcare, so the 17.18% gain cannot be traced to a specific public announcement or event reported by Yahoo Finance.

The absence of recent news headlines makes it impossible to identify a concrete catalyst for the +17.18% move in DH. For a healthcare data and analytics company like Definitive Healthcare, typical catalysts include earnings surprises, contract wins, analyst rating changes, healthcare policy announcements, or strategic partnerships. The stock's extremely low price of $0.95 suggests it may have faced prior distress, making it susceptible to technical trading, short covering, or retail momentum. Without access to earnings calendars, SEC filings, or real-time trading data, the move could reflect a short squeeze, delayed processing of news from outside the 48-hour window, or pure technical/speculative trading in a beaten-down name.

WFF

WF Holding Limited Ordinary SharesIndustrials

$2.02+$0.29

+16.8%

NASDAQ · Mkt cap $20 M

No news headlines were found in the last 48 hours, so the 16.76% gain cannot be directly attributed to a public announcement. The move likely reflects technical trading, delayed news dissemination, or market speculation.

WFF rose 16.76% to rank 26th among daily gainers, but Yahoo Finance returned no relevant news in the prior 48 hours. This disconnect suggests several possibilities. First, a material news event may have occurred but not yet been indexed by the RSS feed or may have been released on company channels before major news wires picked it up. Second, the move could be driven by technical factors such as short covering, options expiration positioning, or rotation into a previously depressed small-cap name. Third, broader sector momentum or a late-breaking announcement not yet reflected in the headlines provided could explain the jump. Without access to the actual news triggering the move, we cannot confirm whether this is a fundamental catalyst or purely technical.

CELU

Celularity Inc.Healthcare

$1.83+$0.26

+16.6%

NASDAQ · Mkt cap $23 M

No news headlines appeared in the last 48 hours to explain the 16.57% gain, so the driver remains unknown; likely candidates are delayed news digestion, technical trading, or untracked corporate developments.

The absence of any recent headlines on Yahoo Finance within 48 hours of this significant single-day jump creates a data gap. CELU is a clinical-stage cell therapy company with a history of volatility, and biotech stocks of this type typically react sharply to clinical trial results, regulatory decisions, financing announcements, or partnership news. The strong gain could reflect a delayed market digestion of older news, short-covering, technical momentum into month-end, or a development announced through non-RSS channels or after the snapshot period. Without access to intraday trading context, press releases, or SEC filings from 2026-08-31 itself, the specific catalyst cannot be identified from the provided evidence. The magnitude of the move (top-30 gainer) suggests a material event rather than random drift.

GODN

Golden Star Acquisition Corporation - Ordinary Shares

$0.85+$0.12

+16.5%

RNXT

RenovoRx, Inc.

$1.93+$0.27

+16.0%

PAII.WT

Pyrophyte Acquisition Corp. II WT

$0.41+$0.06

+15.7%

BESS.WT

$1.50+$0.20

+15.4%

PASW

Ping An Biomedical Co., Ltd.

$0.15+$0.02

+15.3%

NXB

Nextboat Inc

$2.17+$0.29

+15.3%

FAMI

Farmmi IncConsumer Defensive

$0.12+$0.02

+15.2%

NASDAQ · Mkt cap $3.9 M

No news headlines were found in the last 48 hours, so the 15% gain in FAMI stock likely reflects technical trading, delayed news dissemination, or retail interest in a penny stock rather than a specific corporate catalyst.

The absence of any recent news headlines makes it impossible to pinpoint a concrete catalyst for FAMI's +15.17% move. Farmmi is a small-cap agricultural company trading at $0.12 per share, a price point that typically attracts retail traders and short-squeeze activity. Penny stocks often experience outsized volatility on minimal volume or without corresponding news flow, driven by technical bounces, delayed press releases that haven't yet propagated to major RSS feeds, or speculative positioning. It is also possible that a relevant announcement exists but has not yet been indexed by Yahoo Finance's RSS feed. Without a specific headline or confirmed event, the move cannot be reliably attributed to a particular cause.

SYRA

Syra Health Corp. - Class A Common StockHealthcare

$0.92+$0.12

+15.0%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours, so the 15% gain on SYRA likely reflects either a technical bounce, delayed market reaction to an older announcement, or sentiment shift among a thinly traded microcap stock.

The absence of recent headlines is notable for a stock that moved 15% in a single day. SYRA is a healthcare company trading below $1, which typically means lower liquidity and higher sensitivity to small volume shifts or institutional repositioning. Possible explanations for a move of this magnitude without accompanying news include: (1) a technical rebound after oversold conditions, common in low-float stocks that experience sharp prior declines, or (2) delayed market processing of an announcement older than 48 hours that has now gained traction among retail or small-cap-focused traders. Without access to pre-market activity, short interest data, or intraday volume patterns, we cannot determine which mechanism drove the move. Healthcare microcaps can also respond to sector-wide sentiment shifts or commentary in forums that do not surface in traditional news feeds.

TITN

Titan Machinery Inc

$20.53+$2.66

+14.9%

FXHO

Utime Ltd.Technology

$11.92+$1.52

+14.6%

NASDAQ · Mkt cap $54 M

No news headlines were found in the last 48 hours for FXHO, so the 14.62% gain cannot be attributed to a specific disclosed catalyst. The move likely reflects technical trading, a delayed market reaction to older news, or market rumor activity.

The absence of any recent news headlines in the Yahoo Finance RSS feed over the past 48 hours makes it difficult to identify a definitive catalyst for the 14.62% jump in FXHO stock. This is a notable gap given the magnitude of the move and the stock's ranking as the 37th biggest gainer of the day. Without disclosed information, potential drivers could include technical factors such as short covering or momentum trading in a lower-volume name, a delayed market reaction to an earnings report or corporate event that occurred before the 48-hour window, or unverified market rumor activity. Smaller-cap NASDAQ stocks occasionally exhibit sharp moves on thin volume driven by retail interest or algorithmic rebalancing. To properly establish the cause would require examining older press releases, checking if any corporate actions occurred in the preceding week, or reviewing Level 2 trading activity.

LINK

Interlink Electronics, Inc.Technology

$5.76+$0.73

+14.5%

NASDAQ · Mkt cap $81 M

No news headlines were found in the last 48 hours for Interlink Electronics, so the 14.51% gain likely reflects either a delayed market reaction to an older announcement, technical trading activity, or an untracked catalyst.

The absence of any Yahoo Finance RSS headlines in the last 48 hours means we cannot identify a specific news-driven catalyst for this 14.51% jump. Interlink Electronics is a small-cap electronics components manufacturer, a sector and market-cap tier that can exhibit outsized price swings on modest volume or sentiment shifts. Possible explanations for this kind of move without concurrent headlines include: (1) a technical or short-covering event, where the stock broke above a resistance level or prompted covering of existing short positions; (2) a delayed market reaction to an older press release, SEC filing, or contract win that did not appear in the 48-hour RSS feed window; or (3) an industry-specific catalyst such as an auto supply contract or electronics uptick in demand that has not yet been formally announced but may be evident to informed traders. Without a headline anchor, any attribution remains speculative.

JCSE

JE Cleantech Holdings Limited

$1.52+$0.19

+14.3%

EWAVR

East West Ave Acquisition Corp. Rights

$0.16+$0.02

+14.2%

ZOOZ

ZOOZ Power Ltd. Ordinary Shares

$6.77+$0.84

+14.2%

RIBBR

Ribbon Acquisition Corp Rights

$0.27+$0.03

+14.0%

NASDAQ · Mkt cap $1.2 M

No news headlines were published in the last 48 hours, so the 14% gain in RIBBR rights appears driven by technical or market-specific factors rather than a discrete corporate event.

Ribbon Acquisition Corp Rights are a specialized security tied to a SPAC structure. Rights typically trade with lower liquidity and can exhibit outsized percentage moves on modest absolute dollar volume. The absence of recent headlines means the jump was not triggered by identifiable corporate news such as a merger announcement, funding event, or business update. For rights-based securities, catalysts often include: (1) movement in the underlying warrant or common stock following SPAC developments or dissolution timelines; (2) technical or momentum-driven trading in a thinly traded name; or (3) coordinated interest in the broader SPAC or blank-check environment. Without specific structural data on RIBBR's current SPAC stage or any recent filings, it is difficult to pinpoint which mechanism applied here.

GPACW

Global Partner Acquisition Corp II

$0.29+$0.04

+14.0%

IHT

InnSuites Hospitality TrustReal Estate

$1.34+$0.18

+13.8%

NYSE · Mkt cap $15 M

InnSuites announced completion of a $3 million debt-to-equity conversion on August 19 and signaled ongoing reverse merger discussions, strengthening its balance sheet and fueling investor optimism about the company's strategic direction and financial stability.

The news headline confirms two concrete catalysts. First, the company completed a material debt-to-equity conversion worth $3 million, which reduces leverage and improves the balance sheet—a universally positive signal for a small-cap hospitality REIT trading at $1.34. Second, management stated that reverse merger discussions are continuing, which signals potential M&A activity or strategic transformation. For a distressed or underperforming equity like IHT, news of deleveraging combined with active merger discussions can trigger strong short-covering and renewed investor interest. The timing of the announcement on August 31 aligns precisely with the day's 13.85% gain, making the causal link direct and credible.

GFUZ

General Fusion Group Ltd.Industrials

$8.00+$0.98

+13.8%

NASDAQ · Mkt cap $649 M

No news headlines were found in the last 48 hours for GFUZ, so the 13.82% gain cannot be directly attributed to a specific announced event. The move likely reflects technical momentum, retail interest, or delayed market reaction to untracked news.

General Fusion Group Ltd. jumped 13.82% to rank 45th among daily gainers, yet no news headlines appear in the Yahoo Finance RSS feed for the prior 48 hours. This disconnect between price action and covered news suggests several possible drivers. First, the move could be purely technical: a stock with lower liquidity or smaller float can see outsized percentage gains on moderate volume, especially if options positioning or algorithmic flows trigger buying. Second, this type of move is common in smaller-cap or microcap equity names where retail interest can suddenly concentrate. Third, relevant news may have been published but not yet indexed in the headline feed. Without access to press releases, SEC filings, or social media discussion from the exact trading window, attributing causation is speculative. Earnings reports, partnership announcements, or clinical trial results are typical catalysts for companies in this space, but none are confirmed here.

QUCY

Mainz Biomed N.V.Healthcare

$1.57+$0.19

+13.6%

INTZ

Intrusion, Inc.Technology

$0.91+$0.11

+13.0%

NASDAQ · Mkt cap $14 M

No news headlines were found in the last 48 hours to explain INTZ's 13.05% gain, so the catalyst remains unclear; the jump may reflect technical trading, delayed news flow, or market sentiment shifts in this low-priced stock.

No recent news headlines are available to account for the price movement. INTZ is a small-cap cybersecurity and intrusion detection software company trading at $0.91, which is characteristic of stocks prone to technical trading patterns and momentum swings. Low-priced stocks like this can experience sharp moves on relatively low volume driven by factors including short covering, retail trading activity, or delayed news that hasn't yet appeared in RSS feeds. Without specific catalysts identified in headlines, the 13% gain could reflect accumulated news not yet indexed, a technical bounce from support levels, or sentiment shifts in the cybersecurity sector. The absence of any news within 48 hours is notable and suggests the move may be primarily technical or driven by a non-public factor.

HYFM

Hydrofarm Holdings Group, Inc.Industrials

$0.92+$0.10

+12.7%

NASDAQ · Mkt cap $5.2 M

No news headlines appeared in the last 48 hours, so the 12.72% gain likely reflects either delayed market response to an earlier announcement, technical/short-covering activity, or untracked company news.

Hydrofarm Holdings is a horticulture equipment and supplies company, and a 12.72% single-day jump with zero news coverage in the prior 48 hours is unusual. The move could reflect several plausible causes: a delayed market reaction to earnings or guidance released earlier that week, short covering given the stock trades at a very low price point of $0.92 which often attracts retail and short-squeeze attention, technical buying from a support level, or a company announcement that has not yet been indexed by major news feeds. Alternatively, the move could be driven by sector momentum in agriculture or indoor farming, though no specific catalyst is evident. Without contemporaneous headlines, the evidence is insufficient to pinpoint a concrete driver.

ASST

Asset Entities Inc.Financial Services

$24.23+$2.74

+12.6%

NASDAQ · Mkt cap $2.3 B

ASST surged 12.6% on August 31st amid a broader wave of corporate treasury Bitcoin buying, with headlines showing rival asset managers like Strive breaking multi-week buying pauses and renewed institutional adoption of Bitcoin, which likely boosted this smaller Bitcoin treasury stock's momentum.

The news cycle on August 31st centered on major corporate treasuries resuming Bitcoin purchases after a prolonged pause, with Strive announcing a $370 million buy that reportedly drove rival stocks harder than Bitcoin itself. One headline explicitly noted that ASST has nearly doubled in August while larger competitor MSTR gained roughly 30 percent, suggesting ASST is positioned as a smaller, more volatile play in the corporate Bitcoin treasury space. The headlines establish that institutional Bitcoin demand returned on the back of ETF inflows and Washington policy clarity, creating tailwinds for Bitcoin treasury stocks broadly. However, the news does not contain any ASST-specific announcement or earnings result; the move appears to be driven by sector rotation and relative outperformance of smaller-cap players in this category rather than company-specific news.

HEPA

Hepion Pharmaceuticals IncHealthcare

$0.09+$0.01

+12.5%

NASDAQ · Mkt cap $5.5 M

No news headlines were found in the last 48 hours, so the 12.5% gain in HEPA stock is likely driven by technical factors, delayed news, or market rumors rather than a confirmed corporate announcement.

The absence of any recent news headlines in the Yahoo Finance RSS feed over the past 48 hours makes it difficult to pinpoint a specific catalyst for the move. HEPA is a small-cap biopharmaceutical company trading at $0.09, and stocks in this category are particularly susceptible to technical bounces, short covering, retail trading activity, or unconfirmed rumors that may not yet be reflected in major news feeds. The stock's low price and rank as the 50th biggest gainer suggest either a modest absolute volume move or renewed speculative interest. Without confirmed news, the gain could reflect positive sentiment around clinical trial data, partnership discussions, or simply a reversal of prior weakness, but these remain hypotheses rather than established facts.

Biggest Losers

Mon, Aug 31, 2026 50

EYES

Second Sight Medical Products Inc

$1.39−$28.71

-95.4%

ASPCR

A SPAC III Acquisition Corp.

$0.07−$0.06

-45.8%

NASDAQ

No news headlines were found in the last 48 hours to explain the 45.77% drop, making the cause unclear without additional market context or announcements.

ASPCR is a SPAC (special purpose acquisition company) trading at $0.07, suggesting it is either in late-stage dissolution, has failed to complete a merger within its timeline, or is experiencing severe redemption pressure. SPACs at this price level and showing this magnitude of loss typically face structural headwinds such as failed merger negotiations, upcoming trust liquidation deadlines, redemption cascades, or regulatory complications. Without any news in the past 48 hours, the drop could reflect a delayed market reaction to previously disclosed events, an imminent deadline announcement expected after market close, or cumulative investor losses as the SPAC approaches expiration. The absence of fresh headlines makes it difficult to pinpoint whether this is fundamental deterioration or technical selling pressure tied to known SPAC mechanics.

FNGR

FingerMotion, Inc.Communication Services

$0.22−$0.18

-45.3%

NASDAQ · Mkt cap $14 M

No news headlines were available in the last 48 hours to explain the 45.27% drop, making the cause unclear but possibly tied to delayed earnings, a clinical setback, or broader micro-cap volatility.

The absence of any news in the last 48 hours is notable given the severity of the move, with FNGR ranking as the third-largest loser on NASDAQ today. FingerMotion is a micro-cap biotech or medical device company, and such stocks are sensitive to several catalyst types that may not always appear immediately in major RSS feeds: delayed earnings releases, clinical trial results, FDA feedback letters, short seller reports, or insider selling disclosures. It is also possible that news broke late or on a smaller wire service not captured by Yahoo Finance. Without access to the company's investor relations page, regulatory filings, or alternative news sources, the specific catalyst remains unknown. Technical selling, margin calls, or rotation out of micro-cap names during market stress are also plausible but generic explanations.

ROC

ROC Energy Acquisition Corp.

$2.47−$1.83

-42.6%

NASDAQ · Mkt cap $83 M

No news headlines are available in the last 48 hours to explain the 42.56% drop, making the specific catalyst unclear. Given ROC's SPAC-like status and illiquid trading patterns, the move could reflect warrant expiration, redemption pressure, or delayed news.

The absence of any news headlines in the last 48 hours is notable given the severity of this intraday decline, which ranks as the fourth worst performer on NASDAQ. ROC Energy Acquisition Corp. appears to be a special-purpose acquisition vehicle or SPAC-related entity. For such securities, large single-day moves often stem from structural catalysts rather than operational news: warrant expiration or exercise deadlines, shareholder redemption announcements, changes to merger terms, or delayed earnings or regulatory filings hitting the market. The lack of any headline coverage suggests either the news has not yet been published by major outlets, the move reflects technical selling or redemption mechanics specific to SPAC shareholders, or an announcement was made through other channels not captured in the RSS feed. Without access to the company's recent filings or press releases, the precise cause remains speculative.

SVVC

Firsthand Technology Value Fund IncFinancial Services

$0.01−$0.00

-30.0%

NASDAQ · Mkt cap $49 K

No news headlines were found in the last 48 hours, so the 30% drop in SVVC cannot be directly attributed to a specific catalyst; the move is likely driven by technical selling, fund outflows, or portfolio adjustments in a thinly-traded closed-end fund.

SVVC is a closed-end fund focused on venture and technology investments, which typically trade at steep discounts to net asset value and experience high volatility on thin trading volumes. The absence of any news in the last 48 hours means the price action cannot be tied to fund-specific announcements, earnings releases, or portfolio company events. For a stock trading at $0.01 with such a dramatic single-day loss, the most likely explanations fall into two categories: first, technical or momentum-driven selling triggered by a prior breakdown in price support; second, a broader shift in fund flows or sentiment toward venture-focused vehicles, possibly tied to broader venture capital market weakness or redemption pressures. Without access to trading volume data, insider transactions, or fund NAV movements, any specific cause remains speculative.

WTER

Alkaline Water Co Inc-TheConsumer Defensive

$0.02−$0.01

-28.6%

NASDAQ · Mkt cap $1.1 M

No news headlines were published in the last 48 hours to explain the 28.57% drop in WTER stock, so the cause remains unclear based on available information.

The absence of any recent news headlines makes it impossible to pinpoint a specific catalyst for today's 28.57% decline in Alkaline Water Company stock. Penny stocks like WTER are typically volatile and sensitive to multiple potential drivers including broader market sentiment, technical trading patterns, short interest dynamics, or delayed announcements that may not yet be widely covered by financial media. The stock trades at $0.02, which places it in the extreme microcap category where price movements can be exaggerated by low liquidity and high speculative positioning. Without headline confirmation, the drop could stem from a negative company development, sector headwinds, profit-taking, or algorithmic trading responses to technical levels.

BSAAR

BEST SPAC I Acquisition Corp. Rights

$0.09−$0.04

-28.0%

MIMI

Mint Incorporation LimitedIndustrials

$0.83−$0.28

-27.2%

NASDAQ · Mkt cap $14 M

No news headlines were found in the last 48 hours for MIMI, so the 27% single-day drop likely reflects either a delayed market reaction to an untracked event, technical selling pressure, or undisclosed company-specific developments.

The absence of any news in Yahoo Finance RSS over the past two days makes it impossible to pinpoint a specific catalyst for the 27% decline. This scale of move in a micro-cap stock typically correlates with material events such as earnings disappointments, insider selling, dilutive financing announcements, regulatory setbacks, or shifts in market sentiment toward the sector. Given that MIMI trades at $0.83 and ranked as the eighth biggest loser on the day, it is plausible that a significant announcement either predates the 48-hour window captured here, was released outside mainstream financial feeds, or reflects cumulative technical weakness in a thinly traded security. Without corroborating headlines or public filings visible in the data provided, the root cause remains opaque.

GCL

GCL Global Holdings Ltd Ordinary SharesCommunication Services

$0.51−$0.17

-25.3%

NASDAQ · Mkt cap $74 M

No news headlines were found in the last 48 hours, so the 25% drop on August 31 cannot be directly tied to any reported event. The move likely reflects market sentiment, technical selling, or an unannounced development not yet surfaced in major news outlets.

GCL Global Holdings is a small-cap stock trading at $0.51, and the absence of news coverage in the immediate window does not rule out material events. Penny stocks and low-priced securities are frequently subject to technical volatility, short-covering, or thematic sector rotation independent of press releases. A 25% intraday drop of this magnitude at this price level could reflect profit-taking after a run-up, sector headwinds in renewable energy or manufacturing (GCL's typical business focus), or delayed disclosure of negative guidance or operational issues. Without headlines, the most probable categories are either technical/sentiment-driven selling or an event that has not yet been picked up by the news wire services tracked by Yahoo Finance.

UAC.WT

$0.60−$0.20

-25.0%

AAC.WT

Ares Acquisition Corporation Re

$0.72−$0.23

-24.2%

DAIC

CID HoldCo, Inc.Technology

$3.53−$1.04

-23.9%

NASDAQ · Mkt cap $508 K

No news headlines were available in the last 48 hours to explain DAIC's 23.93% single-day decline, making the cause unclear without additional market data or company-specific information.

The absence of any recent news headlines leaves the catalyst for this sharp 23.93% drop unexplained by announced events. DAIC (CID HoldCo, Inc.) experienced a significant equity wipe, landing it among the day's twelve biggest losers, yet no earnings release, guidance cut, regulatory action, or M&A announcement appears in the available news feed. For a stock trading at this price level and magnitude of loss, plausible unexplained catalysts typically include: a delayed earnings miss or missed guidance disclosure not yet syndicated to major news feeds, sector-wide pressure or correlation with a broader market or health-care downturn if DAIC operates in that space, or technical liquidation triggered by stop-losses or margin calls. Without access to intraday broker reports, earnings calendars, or company filings issued in the last 48 hours, determining whether this was fundamentals-driven or purely technical remains speculative.

ZSQR

Z Squared Inc.Technology

$2.95−$0.93

-23.7%

NASDAQ · Mkt cap $218 M

No news headlines were found in the last 48 hours, so the 23.71% drop cannot be attributed to a specific announced event; the move may reflect technical selling, sector weakness, delayed market reaction to older news, or untracked catalysts.

Yahoo Finance returned no headlines for ZSQR in the 48-hour window preceding this steep decline, which eliminates the most straightforward explanations (earnings surprise, guidance revision, product announcement, regulatory action). A drop of this magnitude—ranking 13 worst performer on the day—typically correlates with material corporate news, significant insider activity, or broader market contagion. Without access to the headlines, this analysis cannot identify the triggering catalyst. Possible categories of cause include: (a) a delayed market reaction to news published before the 48-hour window, (b) sector-wide or market-wide technical liquidation affecting small-cap stocks disproportionately, (c) company-specific developments not yet indexed by major news aggregators, or (d) trading-related factors such as short covering reversals or options expiration effects. The absence of news does not prove absence of cause, only that the cause is not visible in the provided data.

EIX

Edison InternationalUtilities

$53.97−$16.17

-23.1%

NYSE · Mkt cap $22 B

Edison International crashed 23% after California lawmakers removed a liability cap for utilities in new wildfire legislation, exposing the company to potentially unlimited financial exposure for fire-related damages.

Multiple headlines from August 31, 2026 establish that California Governor Gavin Newsom and state legislators reached a deal on wildfire legislation that explicitly omits liability protections for utilities like Edison International and PG&E. The bill limits liability for insurers but leaves utilities exposed to what analysts at BMO Capital called "open-ended wildfire-related tail risk." This represents a material shift in the regulatory and financial landscape for California utilities, as they can now face uncapped financial liability for wildfire damages. Wall Street analysts responded immediately with warnings about credit rating implications and investor exposure. The timing—announcement over the weekend, market reaction on Monday—explains the sharp single-day decline. Some retail investors characterized the selloff as an overreaction, but the removal of a previously expected liability shield is a substantive negative catalyst for the sector.

QLEP.WT

Quantum Leap Acquisition Corp WT

$0.12−$0.04

-22.6%

EONR.WT

EON Resources Inc WT

$0.07−$0.02

-21.9%

CPIX

Cumberland Pharmaceuticals Inc

$6.70−$1.81

-21.3%

DUO

Fangdd Network Group Ltd

$0.75−$0.20

-20.9%

RFAI

RF Acquisition Corp II Ordinary SharesFinancial Services

$43.00−$11.20

-20.7%

NASDAQ · Mkt cap $93 M

No news headlines were found in the last 48 hours, so the 20.66% drop cannot be directly attributed to a disclosed event. RFAI is a SPAC, and such vehicles are prone to sharp reversals on redemption pressure, deal termination risk, or extension votes.

The absence of headlines in the 48-hour window means no specific catalyst is documented in the provided data. RFAI is an RF Acquisition Corp SPAC, a blank-check acquisition vehicle. SPACs are structurally volatile and often experience sharp declines when investors exercise redemption rights before a merger closes, when announced deals face regulatory or shareholder hurdles, or when extensions are voted down. The magnitude of the drop (nearly 21%) and its rank as the 19th biggest loser suggests a material event, but without news coverage it could stem from an extension vote result, informal deal headlines via social media not yet picked up by RSS, or redemption mechanics specific to the deal timeline. Without seeing the actual news, you cannot rule out a delayed filing, insider trading halt, or sponsor withdrawal.

COOT

Australian Oilseeds Holdings Limited

$0.60−$0.15

-20.4%

PCG

PG&E CorpUtilities

$13.28−$3.34

-20.1%

NYSE · Mkt cap $31 B

PG&E shares crashed 20% after California lawmakers removed wildfire liability protections from amended legislation, leaving the utility exposed to potentially unlimited financial risk from future wildfire claims.

The California State Assembly amended Senate Bill 492 to exclude liability caps for utilities, which represents a direct reversal of protections that PG&E and Edison International had been seeking. Multiple headlines confirm this legislative action occurred over the weekend, with the stock falling sharply in premarket trading Monday morning and continuing lower throughout the session. Both Wells Fargo and BMO Capital Markets downgraded PG&E following the announcement, citing exposure to open-ended wildfire-related tail risk. The consistency of messaging across financial sources and the precise timing of the stock decline to legislative action makes this a straightforward cause-and-effect relationship. The 20% decline reflects investor repricing of the company's risk profile given the potential for catastrophic uninsured or under-insured liabilities related to future California wildfires.

AEMD

Aethlon Medical IncHealthcare

$2.03−$0.44

-17.8%

NASDAQ · Mkt cap $1.5 M

No news headlines were found in the last 48 hours, so the 17.82% decline likely reflects either a delayed market reaction to an earlier announcement, technical selling pressure, or company-specific developments not yet captured in the news feed.

Aethlon Medical is a micro-cap biotech company focused on extracorporeal therapeutic device technology. The absence of any news in the last 48 hours makes pinpointing the precise catalyst difficult. For a stock of this size and sector, sharp single-day drops can result from several sources: delayed disclosure of clinical trial results or regulatory setbacks, sector-wide biotech selloffs tied to broader market moves, short-squeeze unwind, or insider selling. Micro-cap biotech stocks are also sensitive to liquidity events and can be subject to technical momentum reversal. Without access to current intraday volume, insider transactions, or delayed news feeds, the specific trigger remains unclear, though this magnitude of move in a small-cap biotech typically suggests either material company news or significant technical breakdown.

GIWWR

GigCapital8 Corp. Rights

$0.22−$0.05

-17.5%

EMISR

Emmis Acquisition Corp. Rights

$0.11−$0.02

-17.3%

NASDAQ

No news headlines were reported in the last 48 hours, so the 17% drop is not attributable to a tracked public announcement. The decline likely reflects either technical selling pressure, warrant/rights expiration dynamics, or broader SPAC-related delisting or liquidation risk.

Emmis Acquisition Corp. Rights (EMISR) experienced a sharp single-day decline with zero contemporaneous news coverage in the provided sources. Rights offerings attached to blank-check companies are highly sensitive to the parent SPAC's status and merger prospects. Typical drivers of such moves in this category include expiration of redemption windows, announcement of failed merger negotiations, regulatory delays, or market-wide deleveraging in SPAC-related instruments. Without headline confirmation, the cause remains speculative, but rights on acquisition vehicles often trade on forward-looking sentiment about deal probability and timing rather than discrete events. The ranking as 24 biggest loser suggests this was a sector-wide or category-specific selloff rather than an isolated technical glitch.

GreenPower Motor Company Inc.

$1.04−$0.22

-17.2%

RDIB

Reading International IncCommunication Services

$15.31−$3.10

-16.8%

NASDAQ · Mkt cap $204 M

No news headlines were found in the last 48 hours, so the 16.84% drop in Reading International stock cannot be attributed to any publicly reported event, leaving the specific catalyst unclear.

The absence of recent news headlines makes it difficult to pinpoint the exact cause of the sharp 16.84% decline. Reading International is a cinema and live entertainment operator, a sector sensitive to macroeconomic conditions, consumer discretionary spending, and operational challenges at individual properties. Without specific catalyst information, the drop could stem from several plausible but unconfirmed sources: a delayed earnings disappointment, an internal operational issue at one of its venues, sector-wide weakness in theatrical releases or attendance trends, changes in debt covenant status or refinancing concerns, or broader market rotation away from discretionary entertainment stocks. Technical factors or accumulated selling pressure ahead of an earnings announcement could also explain the magnitude of the move. The lack of contemporaneous news reporting is notable and suggests either the catalyst is not yet public or the market is reacting to anticipated information.

GIPR

Generation Income Properties Inc.Real Estate

$0.36−$0.07

-16.8%

NASDAQ · Mkt cap $253 K

No news headlines were found in the last 48 hours to explain GIPR's 16.76% drop, so the cause remains unclear; the decline may reflect broader market conditions, sector weakness, or undisclosed company developments.

The absence of any news coverage in the past 48 hours makes it difficult to pinpoint a specific catalyst for this sharp intraday loss. GIPR is a real estate income trust, a category that can be sensitive to interest rate movements, market sentiment shifts, and portfolio rebalancing activity. Possible explanations include sector-wide pressure on real estate equities, a delayed market reaction to older news not captured in the last 48 hours, insider selling, or technical selling pressure unrelated to fundamental developments. Without access to trading volume data, insider filings, or broader market context for that date, we cannot distinguish between these scenarios. It is also possible a material announcement occurred outside the news feeds provided here.

TRON

Toron, Inc.Consumer Cyclical

$1.75−$0.34

-16.5%

TECX

Tectonic Therapeutic, Inc.Healthcare

$29.84−$5.85

-16.4%

NVNI

Nvni Group Limited - Ordinary SharesTechnology

$0.84−$0.16

-16.3%

NASDAQ · Mkt cap $12 M

No news headlines were published in the last 48 hours for NVNI, so the 16.31% drop cannot be directly attributed to a reported event; the decline may reflect broader market dynamics, technical selling, or private information not yet public.

The absence of any recent news headlines makes it impossible to anchor the decline to a specific catalyst. NVNI is a micro-cap stock trading at $0.84, which historically have been sensitive to liquidity events, momentum reversals, short covering unwinds, and retail sentiment shifts that may not generate public news coverage. The stock's ranking as the 30th biggest loser suggests a noteworthy move, but without earnings releases, guidance changes, regulatory actions, or strategic announcements in the record, the cause is not documented. Possible mechanisms include technical breakdown below support, a quiet insider sale or dilutive event not yet disclosed, sector-wide weakness in a segment NVNI belongs to, or pure algorithmic liquidation. Without more context on the company's operations or the broader market conditions on August 31, 2026, attribution remains speculative.

JUNS

Jupiter Neurosciences, Inc.Healthcare

$3.49−$0.67

-16.1%

NASDAQ · Mkt cap $3.7 M

JUNS fell 16.13% on August 31, 2026, but the only recent headline provided is a cannabis and psychedelic sector roundup that does not mention Jupiter Neurosciences specifically or contain material news about the company.

The headline provided is a generic sector update discussing Aurora Cannabis, Curaleaf, and Tilray—none of which are JUNS or directly related to it. The snippet is truncated mid-sentence and offers no specific information about Jupiter Neurosciences' operations, financials, clinical trials, partnerships, or regulatory status. While JUNS operates in the neuroscience/psychedelic space and could theoretically be affected by broad sector sentiment, the headline does not establish that connection explicitly. Without company-specific news, the 16.13% decline likely stems from intraday technical factors, broader biotech weakness, market-wide selloff, short positions, or undisclosed developments not captured in the provided news feed. Smaller-cap neuroscience stocks are often volatile and may move on sentiment shifts unrelated to published headlines.

PCG.PR.X

PG&E Corp

$34.04−$6.52

-16.1%

CYAN

Cyanotech CorpConsumer Defensive

$0.42−$0.08

-16.0%

NASDAQ · Mkt cap $3.3 M

No news headlines were available in the last 48 hours, so the 16% drop cannot be attributed to a specific announced event. The decline likely stems from technical selling, sector weakness, or delayed market reaction to earlier developments not captured in the current news feed.

Cyanotech Corporation experienced a significant 16% single-day decline ranking it the 33rd biggest loser on NASDAQ, yet no news headlines appeared in the Yahoo Finance RSS feed for the preceding 48 hours. This disconnect between magnitude of move and news availability suggests either the catalyst occurred earlier and the market is reacting with a lag, or the decline is driven by technical factors such as stop-loss triggers, sector rotation out of specialty biotech or nutritional products, or broader market dynamics unrelated to company-specific developments. For a small-cap stock like CYAN, intraday volume spikes or short covering can also exacerbate moves. Without recent headlines, the specific trigger remains unknown.

FLYE

International Jet Engine Supply, Inc.Consumer Cyclical

$1.37−$0.26

-16.0%

NASDAQ · Mkt cap $2.9 M

No news headlines were published in the last 48 hours about FLYE, so the 15.95% drop cannot be directly attributed to reported company news or events. The decline likely stems from sector headwinds, technical selling, or non-public market developments.

The absence of any recent news coverage for a stock experiencing a significant intraday drop is notable. For a small-cap aerospace supplier like International Jet Engine Supply, declines of this magnitude can result from several common drivers: broad sector selloffs in aerospace or defense, technical breakdown through key support levels triggering stop-loss orders, dividend or earnings disappointment that may have been announced earlier but not yet indexed into price, analyst downgrades, or institutional rebalancing. Without access to real-time order flow data, company filings, or wire service alerts outside the RSS feed provided, we cannot pinpoint which of these categories applies. The lack of headline coverage suggests the move may reflect delayed market reaction to earlier news, or movement driven by technical or portfolio factors rather than company-specific catalysts.

AEHL

Antelope Enterprise Holdings LimitedIndustrials

$6.48−$1.04

-15.8%

NASDAQ · Mkt cap $6.5 M

No financial news or company headlines emerged in the last 48 hours to explain AEHL's 15.81% decline, suggesting the move may reflect broader market conditions, technical selling, or undisclosed company developments not yet reported.

The 15.81% single-day drop in AEHL occurred without any identifiable news catalyst in the Yahoo Finance RSS feed over the past two days. This absence of headline coverage does not rule out a cause but limits our ability to confirm one. For a stock trading at $6.48 on NASDAQ, typical catalysts for sharp declines include earnings misses or guidance cuts, sector rotation out of the company's industry segment, a short seller report or research downgrade not yet widely circulated, insider selling announcements, or technical breakdown through key support levels. Without access to real-time tape data or company filings released today, we cannot determine which of these scenarios, if any, applies to AEHL specifically.

ESAC

ESGEN Acquisition Corporation Class A Ordinary Shares

$0.24−$0.04

-15.1%

SXTC

China SXT Pharmaceuticals IncHealthcare

$2.56−$0.46

-15.1%

NASDAQ · Mkt cap $2.4 M

No news headlines were found in the last 48 hours, so the 15% decline cannot be attributed to any identifiable corporate announcement or public catalyst. The drop likely reflects technical selling, sector headwinds, or unannounced company-specific developments.

The absence of recent news in the search results means we cannot point to a specific earnings miss, FDA decision, financing event, or guidance change as the cause of this sharp decline. For a small-cap pharmaceutical company like SXTC trading on NASDAQ, a 15% single-day loss without disclosed news could stem from several typical triggers: delayed or negative clinical trial data that hasn't yet appeared in mainstream feeds, insider selling or lock-up expiration, deterioration in broader biotech sentiment, or a private placement or dilutive financing announcement made through channels not yet reflected in Yahoo Finance RSS. Alternatively, technical factors such as stop-loss cascades or short covering reversals can drive moves of this magnitude in lower-liquidity stocks. Without access to SEC filings, company press releases, or social media channels, the precise catalyst remains unknown.

ZEO

ESGEN Acquisition Corporation

$0.24−$0.04

-15.1%

XLAB

Exascale Labs Holdings Inc. Class A

$4.25−$0.75

-15.1%

BGM

Qilian International Holding Group Ltd.Healthcare

$0.27−$0.05

-14.7%

NASDAQ · Mkt cap $112 M

BGM dropped 14.71% with no news headlines in the last 48 hours, so the catalyst remains unclear; the decline likely stems from technical selling, broader market weakness, or undisclosed company developments.

No headlines were available in the last 48 hours to explain BGM's sharp 14.71% decline, making it impossible to attribute the move to a specific announced catalyst such as earnings, guidance, or a corporate action. BGM is a shell company operating in Hong Kong as part of the Qilian International group, trading at $0.27 on the NASDAQ, which typically signals low liquidity and high volatility. For micro-cap stocks in this price range, moves of this magnitude often occur due to technical factors, algorithmic liquidation, or undisclosed rumors rather than publicly announced news. The absence of headlines does not rule out significant company-specific developments; material news may have been released through other channels or may not yet have reached broad financial media. Alternatively, the decline could reflect broader selling in Chinese equities or systematic outflows from penny-stock positions.

DTCX

Thumzup Media Corporation

$2.22−$0.38

-14.6%

VVOS

Vivos Therapeutics, Inc.Healthcare

$0.20−$0.03

-14.4%

NASDAQ · Mkt cap $3.8 M

No news headlines were found in the last 48 hours, so the 14.44% drop cannot be directly attributed to a disclosed catalyst; the decline likely reflects broader biotech weakness, technical selling, or undisclosed market developments.

Vivos Therapeutics is a clinical-stage biotech company, and the absence of recent news headlines means we cannot point to a specific catalyst like trial results, FDA action, or guidance changes. Biotech stocks of this size and stage are particularly sensitive to several factors: funding concerns or dilution announcements that may not immediately surface in major news feeds, shifts in investor risk appetite toward small-cap therapeutics, technical selling into support levels, or delayed market reactions to older announcements. The stock's position as the 42nd biggest loser suggests this is part of a broader sector or market movement rather than an isolated event, which would favor explanations like sector rotation or market-wide risk-off trading rather than company-specific news.

ALGS

Aligos Therapeutics IncHealthcare

$5.86−$0.99

-14.4%

NASDAQ · Mkt cap $43 M

No news headlines were found in the last 48 hours, so the 14.42% drop cannot be directly attributed to a disclosed catalyst. Biotech stocks like Aligos often move sharply on clinical trial results, regulatory decisions, or funding news.

The absence of any news in the Yahoo Finance RSS feed in the last 48 hours means there is no identifiable headline-based explanation for today's decline. Aligos Therapeutics is a clinical-stage biotech company, and stocks in this category are typically highly sensitive to binary events: Phase trial outcomes, FDA decisions, capital raises, partnership announcements, or changes in cash runway. The 14.42% drop could reflect a delayed market reaction to older news not captured in the 48-hour window, broader sector weakness in biotech, or a private development that has not yet been publicly disclosed or indexed. Without access to intraday volumes, short interest data, or real-time proprietary feeds, the specific driver remains unknown.

AIM

AIM ImmunoTech Inc.Healthcare

$0.23−$0.04

-13.9%

NYSE · Mkt cap $7.3 M

AIM ImmunoTech announced a U.S. patent for Ampligen combined with Keytruda through 2039, a potentially positive development, yet the stock fell 13.93%, suggesting the market either discounted the news as insufficient to drive near-term value or reacted to unrelated negative catalysts not captured…

The headline reports a genuinely positive event: a broad U.S. patent covering the combination of Ampligen (rintatolimod) with pembrolizumab (Keytruda) across multiple cancer indications, with protection extending to 2039. This reinforces intellectual property protection and could support long-term commercial prospects. However, a 13.93% decline on the same day suggests the market either viewed the patent as priced-in, insufficient to justify current valuation, or unimpressive given the pipeline's clinical standing. Alternatively, the decline may reflect broader biotechnology sector weakness, a separate clinical setback, financing news, or short-covering unrelated to this announcement. Without additional headlines or context on the company's cash position, clinical trial status, or market sentiment toward immuno-oncology stocks, we cannot definitively attribute the drop to the patent announcement itself.

OESX

Orion Energy Systems IncIndustrials

$22.89−$3.62

-13.6%

NASDAQ · Mkt cap $76 M

No news headlines were found in the last 48 hours for OESX, so the 13.64% drop likely reflects either delayed market reaction to an untracked announcement, broad sector weakness, or technical selling pressure.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for the 13.64% decline. Orion Energy Systems is a renewable energy and energy management company, and stocks in this sector can be sensitive to several factors not necessarily captured in 48-hour RSS feeds: shifts in energy policy expectations, changes in solar or efficiency subsidy narratives, quarterly results that may have been released or previewed outside the headline window, analyst downgrades, or shifts in broader clean-energy sentiment. It is also possible the move reflects profit-taking after a recent rally or general market rotation out of growth-oriented or renewable-energy stocks. Without news directly tied to the company, the most likely categories of cause are sector headwinds, delayed earnings impact, or technical momentum reversal.

TENX

Tenax Therapeutics IncHealthcare

$1.84−$0.29

-13.6%

CRE

Cre8 Enterprise LimitedIndustrials

$3.21−$0.50

-13.5%

NASDAQ · Mkt cap $5.2 M

No news headlines were found in the last 48 hours for CRE, so the 13.51% decline cannot be directly attributed to a specific announced catalyst; the move likely reflects technical selling, sector rotation, or delayed market reaction to an undisclosed event.

The absence of recent news headlines makes it impossible to pinpoint a confirmed cause for CRE's sharp 13.51% drop on August 31, 2026. For a small-cap or micro-cap stock like this, price declines of this magnitude absent public news can arise from several sources: technical chart breaks or stop-loss cascades, sector-wide rotation out of growth or speculative names, liquidity events tied to fund redemptions, delayed market reaction to news that broke outside the 48-hour window, or undisclosed corporate developments that have not yet reached major financial news feeds. Without access to insider trading activity, short interest data, or knowledge of the company's operational status, we cannot distinguish between these hypotheses. The ranking as the 47th biggest loser suggests broad market participation in the decline rather than a single stock-specific shock.

LSTA

Lisata Therapeutics IncHealthcare

$1.50−$0.22

-12.8%

NASDAQ · Mkt cap $10 M

No news headlines were found in the last 48 hours, so the 12.79% drop likely stems from sector weakness, technical selling, or an untracked announcement specific to this small-cap biotech company.

The absence of any Yahoo Finance headlines in the last 48 hours means the price decline cannot be attributed to a tracked corporate event such as earnings, FDA decisions, clinical trial results, or management changes. Lisata Therapeutics is a small-cap biopharmaceutical company, and stocks in this category are prone to sharp moves on limited volume, technical breakdowns, or news flow that may not yet appear in major financial RSS feeds. The drop could reflect sector-wide pressure on biotech equities, profit-taking after a prior run, short covering reversal, or an announcement made through a less widely syndicated channel. Without corroborating data, any specific attribution would be speculation.

AMPGZ

Amplitech Group, Inc. Series B Right

$0.21−$0.03

-12.8%

NASDAQ

No news headlines were found in the last 48 hours to explain the 12.78% decline in AMPGZ, so the drop likely reflects either profit-taking in a low-liquidity rights security, broader market weakness, or a delayed reaction to an earlier announcement not captured in the news feed.

The absence of any news in the past two days makes direct attribution impossible. AMPGZ is a Series B right offering from Amplitech Group, a specialized security with typically thin trading volume and low absolute price. Rights offerings are inherently time-sensitive instruments with declining value as expiration approaches, which alone can drive sharp percentage moves on modest share volume. The stock could be experiencing routine liquidation ahead of rights expiration, technical selling after a prior rally, or spillover from broader semiconductor or defense-related sector weakness if Amplitech operates in those verticals. Without current headlines or knowledge of the exact expiration date and current market conditions for this specific right, we cannot isolate the precise trigger. The ranking as a top-50 loser suggests some selling pressure, but that must be weighted against AMPGZ's naturally high percentage volatility due to its low nominal price.

FLYX.WT

flyExclusive, Inc.

$0.11−$0.02

-12.6%